The European Union has awarded a grant of 6,4 € million for the research project SBR (Smart Bone Regeneration) to improve treatment options for patients with large bone defects.
This 4-year project has been granted under the H2020 call: Regenerative medicine – from new insights to new applications.
The SBR consortium comprises the coordinator, Professor Sophia Antimisiaris from the University of Patras, Greece and 9 European partners from 6 countries, including Asphalion as regulatory partner.
The SBR kick-off meeting is taking place on 5-6 February 2020 in Greece and Dominique Monferrer, Scientific & Regulatory Affairs Associate Director and Eduardo Garrido, Scientific & Regulatory Affairs Officer, at Asphalion, are already there.
Within the SBR project, Asphalion will provide continuous regulatory support to all partners during the whole duration of the project. We are proud to participate in the consortium and are looking forward to begin this challenging collaboration with all partners.
More details about the SBR project: https://www.asphalion.com/novel-regeneration-techniques-for-large-bone-defects-launch-of-eu-research-project-sbr/
The SBR project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874896.
